Phase
Condition
Pancreatitis
Pancreatic Disorders
Treatment
Search for exocrine pancreatic insufficiency at week 0 and 12
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age of 18 years or more
Crohn's disease diagnosed for more than 3 months.
Active Crohn's disease : CDAI score > 150 + [CRP > 5 mg/L or faecal calprotectin > 250mcg/g or endoscopic lesion or MRI lesion]
Indication of a biological therapy (anti-TNFα, vedolizumab ou ustekinumab).
Exclusion
Exclusion Criteria:
Crohn's disease that doesn't fit the previous criteria
Extended resection of small intestine (>40cm)
Chronic pancreatitis diagnosed before inclusion
Contraindication to biological therapy (anti-TNFα, vedolizumab ou ustekinumab)
Pancreatic enzyme replacement therapy
Pregnant or breastfeeding woman
Patient under the protection of a conservator
Study Design
Connect with a study center
Service d'Hépato-Gastroentérologie, Centre Hospitalier Lyon-Sud, HCL
Pierre Benite, 69495
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.